LivaNova plc (NASDAQ:LIVN) reported Q1 EPS of $0.48, in-line with the analyst estimate of $0.48. Revenue for the quarter came in at $240.2 million versus the consensus estimate of $231.57 million.
GUIDANCE:
LivaNova plc sees FY2022 EPS of $2.50-$2.80, versus the consensus of $2.59. LivaNova continues to expect worldwide net sales for full-year 2022 to grow between 3 and 5 percent on a constant-currency basis after excluding the impact of the Heart Valves divestiture. LivaNova assumes foreign currency is now a 2 to 3 percent headwind.